Home » Topics » Regulatory

Regulatory
RSS

Forest files for FDA approval of Synapton

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Fixed-dose trandolapril/verapamil combination now available in U.K.

Nov. 25, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...